• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟碱样配体的比较结合特性及其药理学

The comparative binding characteristics of nicotinic ligands and their pharmacology.

作者信息

Sloan J W, Martin W R, Bostwick M, Hook R, Wala E

机构信息

University of Kentucky, College of Medicine, Department of Pharmacology, Lexington 40536.

出版信息

Pharmacol Biochem Behav. 1988 May;30(1):255-67. doi: 10.1016/0091-3057(88)90454-6.

DOI:10.1016/0091-3057(88)90454-6
PMID:3174751
Abstract

Five drugs [(-)- and (+)-nicotine, (-)-lobeline, (-)-anabasine and (-)-cytisine] were infused IV into the urethane-pentobarbital anesthetized rat. Changes in heart rate, blood pressure, respiratory rate, minute and tidal volume, which appeared to be largely centrally mediated, were studied. Each of these compounds produced different pharmacologic profiles. The nature of these dissimilarities is not readily explained on the basis of pharmacokinetic considerations suggesting that the drugs have different mechanisms of action. Binding data obtained with these compounds using the rat brain P2 preparation also show differences. (-)-Lobeline and (-)-anabasine, like the nicotinic antagonists mecamylamine and hexamethonium, bind predominantly to low affinity sites with KDs in the micromolar range whereas (-)-cytisine binds only to a single high affinity site with a KD in the nanomolar range. Further, the binding patterns of these drugs are different from (-)- and (+)-nicotine which bind to both high and low affinity sites but differ from each other in binding characteristics. Thus the binding data are consistent with the pharmacologic data in suggesting that the drugs have different modes of action and support the concept that the low affinity site has an important role in the central nervous system action of these compounds.

摘要

将五种药物[(-)-和(+)-尼古丁、(-)-洛贝林、(-)-新烟草碱和(-)-金雀花碱]静脉注射到经氨基甲酸乙酯-戊巴比妥麻醉的大鼠体内。研究了心率、血压、呼吸频率、每分通气量和潮气量的变化,这些变化似乎主要由中枢介导。这些化合物中的每一种都产生了不同的药理学特征。这些差异的性质难以根据药代动力学考虑来解释,这表明这些药物具有不同的作用机制。使用大鼠脑P2制剂获得的这些化合物的结合数据也显示出差异。(-)-洛贝林和(-)-新烟草碱,与烟碱拮抗剂美加明和六甲铵一样,主要与低亲和力位点结合,解离常数在微摩尔范围内,而(-)-金雀花碱仅与单个高亲和力位点结合,解离常数在纳摩尔范围内。此外,这些药物的结合模式与(-)-和(+)-尼古丁不同,(-)-和(+)-尼古丁与高亲和力和低亲和力位点都结合,但在结合特性上彼此不同。因此,结合数据与药理学数据一致,表明这些药物具有不同的作用模式,并支持低亲和力位点在这些化合物的中枢神经系统作用中起重要作用的概念。

相似文献

1
The comparative binding characteristics of nicotinic ligands and their pharmacology.烟碱样配体的比较结合特性及其药理学
Pharmacol Biochem Behav. 1988 May;30(1):255-67. doi: 10.1016/0091-3057(88)90454-6.
2
Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.大鼠脊髓中烟碱型乙酰胆碱受体的配体特异性:尼古丁和金雀花碱的研究
J Pharmacol Exp Ther. 1994 Jul;270(1):159-66.
3
Regulation of brain nicotinic receptors by chronic agonist infusion.慢性激动剂输注对脑烟碱受体的调节作用。
J Neurochem. 1991 Jun;56(6):1932-9. doi: 10.1111/j.1471-4159.1991.tb03450.x.
4
Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.大鼠脑中烟碱受体介导的乙酰胆碱释放的药理学特性——一项体内微透析研究
Eur J Pharmacol. 1998 Jun 19;351(2):181-8. doi: 10.1016/s0014-2999(98)00314-8.
5
Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.神经元烟碱受体β2和β4亚基在激动剂结合亲和力方面存在很大差异。
Mol Pharmacol. 1998 Dec;54(6):1132-9.
6
Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.鞘内注射烟碱类药物后的心血管及行为反应
J Pharmacol Exp Ther. 1994 Jul;270(1):150-8.
7
Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.[3H]金雀花碱、[3H]尼古丁和[3H]甲基氨甲酰胆碱在大鼠脑中的烟碱受体结合情况
Eur J Pharmacol. 1994 Mar 3;253(3):261-7. doi: 10.1016/0014-2999(94)90200-3.
8
Clozapine attenuates the discriminative stimulus properties of (-)-nicotine.氯氮平可减弱(-)-尼古丁的辨别刺激特性。
Brain Res. 1994 Apr 18;643(1-2):1-9. doi: 10.1016/0006-8993(94)90002-7.
9
Nature of nicotine binding to rat brain P2 fraction.尼古丁与大鼠脑P2组分的结合性质。
Pharmacol Biochem Behav. 1984 Jun;20(6):899-909. doi: 10.1016/0091-3057(84)90015-7.
10
Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.通过[3H]尼古丁、[3H]金雀花碱和[3H]埃博霉素B体外放射自显影法测定人脑皮质中烟碱受体亚型的层状分布。
Neuroscience. 1998 Aug;85(4):1121-33. doi: 10.1016/s0306-4522(97)00652-0.

引用本文的文献

1
Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.烟碱型乙酰胆碱受体拮抗作用模式 II:对大鼠心血管的影响。
Drug Alcohol Depend. 2013 Aug 1;131(3):284-97. doi: 10.1016/j.drugalcdep.2012.12.021. Epub 2013 Jan 18.
2
Patterns of nicotinic receptor antagonism: nicotine discrimination studies.烟碱型乙酰胆碱受体拮抗模式:尼古丁辨别研究。
J Pharmacol Exp Ther. 2011 Oct;339(1):194-202. doi: 10.1124/jpet.111.182170. Epub 2011 Jul 5.
3
Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.烟碱型乙酰胆碱受体配体洛贝林对克隆 Kv1.5 的作用。
Pflugers Arch. 2010 Oct;460(5):851-62. doi: 10.1007/s00424-010-0868-3. Epub 2010 Aug 24.
4
Nicotiana glauca (tree tobacco) intoxication--two cases in one family.甜烟(树烟)中毒——一家两例。
J Med Toxicol. 2011 Mar;7(1):47-51. doi: 10.1007/s13181-010-0102-x.
5
In vivo effects of 3-iodocytisine: pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites.3-碘胞嘧啶核苷的体内效应:体温过低的药理学和遗传学分析以及对烟碱结合位点的长期治疗评估
Neuropharmacology. 2009 Sep;57(3):332-42. doi: 10.1016/j.neuropharm.2009.05.004. Epub 2009 May 28.
6
Vesicular monoamine transporter 2: role as a novel target for drug development.囊泡单胺转运体2:作为药物开发新靶点的作用
AAPS J. 2006 Nov 10;8(4):E682-92. doi: 10.1208/aapsj080478.
7
An uncontrolled trial of cytisine (Tabex) for smoking cessation.一项关于金雀花碱(畅沛)戒烟的非对照试验。
Tob Control. 2006 Dec;15(6):481-4. doi: 10.1136/tc.2006.016097.
8
Discriminative stimulus properties of the nicotinic agonist cytisine.烟碱型激动剂金雀花碱的辨别刺激特性。
Psychopharmacology (Berl). 1997 Feb;129(3):257-64. doi: 10.1007/s002130050188.